Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (111-120 of 466) with videos related to

Pageof 47
Sort By:
Lancet (London, England)|November 12, 2016
Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countriesNarcyz Ghinea, Wendy Lipworth, Richard Day, et al.
Journal of the International AIDS Society|August 8, 2017
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Jason Grebely, Gregory J Dore, Sébastien Morin, et al.
Plos One|July 5, 2013
Sequencing of the Hepatitis C Virus: A Systematic ReviewBrendan Jacka, Francois Lamoury, Peter Simmonds, et al.
AIDS (London, England)|June 26, 2003
Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapyGregory J Dore, Ann McDonald, Yueming Li, et al.
Journal of Hepatology|May 8, 2010
Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, AustraliaHeather F Gidding, Janaki Amin, Gregory J Dore, et al.
Journal of Hepatology|September 24, 2022
National trends in retreatment of HCV due to reinfection or treatment failure in AustraliaJoanne M Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Journal of Hepatology|March 10, 2023
Corrigendum to 'National trends in retreatment of HCV due to reinfection or treatment failure in Australia' (J Hepatol [2023] 260-270)Joanne M Carson, Sebastiano Barbieri, Gail V Matthews, et al.
The International Journal on Drug Policy|February 12, 2020
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison settingLise Lafferty, Jake Rance, Jason Grebely, et al.
Sexual Health|April 1, 2020
Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort studyNima Iranpour, Gregory J Dore, Marianne Martinello, et al.
Journal of Viral Hepatitis|August 25, 2018
Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prisonLise Lafferty, Jake Rance, Jason Grebely, et al.
Pageof 47

Showing results (111-120 of 466) with videos related to

Sort By:
Pageof 47
Lancet (London, England)|November 12, 2016
Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countriesNarcyz Ghinea, Wendy Lipworth, Richard Day, et al.
Journal of the International AIDS Society|August 8, 2017
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Jason Grebely, Gregory J Dore, Sébastien Morin, et al.
Plos One|July 5, 2013
Sequencing of the Hepatitis C Virus: A Systematic ReviewBrendan Jacka, Francois Lamoury, Peter Simmonds, et al.
AIDS (London, England)|June 26, 2003
Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapyGregory J Dore, Ann McDonald, Yueming Li, et al.
Journal of Hepatology|May 8, 2010
Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, AustraliaHeather F Gidding, Janaki Amin, Gregory J Dore, et al.
Journal of Hepatology|September 24, 2022
National trends in retreatment of HCV due to reinfection or treatment failure in AustraliaJoanne M Carson, Sebastiano Barbieri, Gail V Matthews, et al.
Journal of Hepatology|March 10, 2023
Corrigendum to 'National trends in retreatment of HCV due to reinfection or treatment failure in Australia' (J Hepatol [2023] 260-270)Joanne M Carson, Sebastiano Barbieri, Gail V Matthews, et al.
The International Journal on Drug Policy|February 12, 2020
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison settingLise Lafferty, Jake Rance, Jason Grebely, et al.
Sexual Health|April 1, 2020
Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort studyNima Iranpour, Gregory J Dore, Marianne Martinello, et al.
Journal of Viral Hepatitis|August 25, 2018
Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prisonLise Lafferty, Jake Rance, Jason Grebely, et al.
Pageof 47